全球乳腺癌患者抑郁症患病率的系统评价和荟萃分析。
Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis.
机构信息
Department of Nursing Education, Nursing and Midwifery School, Jiroft University of Medical Sciences, Jiroft, Iran.
Midwifery Department, Zabol University of Medical Sciences, Zabol, Iran.
出版信息
Breast Cancer Res Treat. 2019 Aug;176(3):519-533. doi: 10.1007/s10549-019-05271-3. Epub 2019 May 13.
PURPOSE
Depression in patients with breast cancer imposes huge costs to patients, families, and healthcare systems. The present study aimed at evaluating the global prevalence depression among patients with breast cancer.
METHODS
In this meta-analysis, three electronic databases (PubMed, Web of Science, and Scopus) were searched from 1 January, 2000 until 30 March, 2019. The Hoy tool was used to evaluate the quality of the articles included in the meta-analysis. The search, screening, quality evaluation, and data extraction were carried out by two of the researchers.
RESULTS
Of 47,424 studies, 72 studies performed in 30 countries entered the final stage of analysis. The global prevalence of depression was 32.2%. Specifically, the prevalence of depression was highest in the Eastern Mediterranean region and twice as high in middle-income countries as compared to developed countries.
CONCLUSIONS
Regarding the high prevalence of depression in patients with breast cancer, it is vital to carry out screening within standard time periods and offer the necessary emotional support.
目的
乳腺癌患者的抑郁状况给患者、家庭和医疗保健系统带来了巨大的成本。本研究旨在评估全球乳腺癌患者的抑郁患病率。
方法
在这项荟萃分析中，从 2000 年 1 月 1 日至 2019 年 3 月 30 日，我们检索了三个电子数据库（PubMed、Web of Science 和 Scopus）。我们使用 Hoy 工具评估了荟萃分析中纳入的文章的质量。搜索、筛选、质量评估和数据提取由两名研究人员进行。
结果
在 47424 项研究中，有 72 项在 30 个国家进行的研究进入了最终分析阶段。全球抑郁症的患病率为 32.2%。具体而言，在东地中海地区抑郁症的患病率最高，而与发达国家相比，中等收入国家的抑郁症患病率是其两倍。
结论
鉴于乳腺癌患者中存在较高的抑郁患病率，在标准时间内进行筛查并提供必要的情感支持至关重要。
Zotero 插件